GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (NAS:INDV) » Definitions » Current Deferred Revenue

INDV (Indivior) Current Deferred Revenue : $0 Mil (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Indivior Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Indivior's current deferred revenue for the quarter that ended in Dec. 2024 was $0 Mil.

Indivior Current Deferred Revenue Historical Data

The historical data trend for Indivior's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indivior Current Deferred Revenue Chart

Indivior Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Indivior Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Indivior Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Indivior's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Indivior Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (NAS:INDV) » Definitions » Current Deferred Revenue
Comparable Companies
LSE:APH LSE:AGY LSE:ANCR LSE:EAH LSE:STX LSE:PXS LSE:CEL LSE:N4P LSE:HCM ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA ITCI
Traded in Other Exchanges
INDVl:UK INDV:UK 2IVB:Germany
Address
10710 Midlothian Turnpike, Suite 125, North Chesterfield, Richmond, VA, USA, 23235
Website
https://www.indivior.com
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.